Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee

PR Newswire April 29, 2024

It's Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team

Accesswire April 23, 2024

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges

PR Newswire April 17, 2024

Abbott Receives FDA Approval for TriClip(TM), First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve

PR Newswire April 2, 2024

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside

PR Newswire April 1, 2024

Abbott Hosts Conference Call for First-Quarter Earnings

PR Newswire March 27, 2024

Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System

Canada NewsWire March 19, 2024

Diabetes and Heart Disease: How to Manage Your Risk

Accesswire March 15, 2024

Abbott Extends Innovative Health Partnership With Real Madrid and the Real Madrid Foundation

Accesswire March 11, 2024

Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes

PR Newswire March 6, 2024

Medical Technology Stocks to Keep On The Radar

TheNewsWire February 20, 2024

Abbott Declares 401st Consecutive Quarterly Dividend

PR Newswire February 16, 2024

FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip(TM) System to Treat People With a Leaky Tricuspid Heart Valve

PR Newswire February 13, 2024

New Study Shows Mixed Reality Technology for Blood Donation From Abbott and Blood Centers of America Helps Ease Stress, Encourages People To Donate Again

Accesswire February 8, 2024

Decade of Impact: Transforming Care in Tanzania

Accesswire February 6, 2024

Abbott Launches New PROTALITY(TM) Brand To Support Adults on Their Weight Loss Journey

Accesswire February 5, 2024

Can a 'Food as Medicine' Approach Help Manage Diabetes?

Accesswire February 2, 2024

New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again

PR Newswire February 1, 2024

Abbott Launches New PROTALITY(TM) Brand to Support Adults on Their Weight Loss Journey

PR Newswire January 31, 2024

Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+

PR Newswire January 25, 2024